Profusa (NVACW) Net Cash Flow (2022 - 2026)
Profusa posted quarterly Net Cash Flow of -$1.4 million for Q1 2026, down 122.58% year-on-year from $6.3 million in Q1 2025, and down 15.92% on a QoQ basis from -$1.2 million in Q4 2025.
Profusa (NVACW) has 5 years of Net Cash Flow data on file, last reported at -$1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 122.58% year-over-year to -$1.4 million; the trailing twelve-month figure through Mar 2026 stood at -$6.2 million (down 165.97% YoY), and the FY2025 full-year result was $1.6 million, down 47.4% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$1.4 million, down from -$1.2 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $6.3 million in Q1 2025 and bottomed at -$6.3 million in Q2 2025.
- The 5-year median for Net Cash Flow is -$49799.0 (2023), against an average of $141576.1.
- Peak annual rise in Net Cash Flow reached 794662.14% in 2025, while the deepest fall reached 535870.9% in 2025.
- A 5-year view of Net Cash Flow shows it stood at -$179385.0 in 2022, then surged by 92.85% to -$12823.0 in 2023, then jumped by 4068.93% to $508936.0 in 2024, then plunged by 341.88% to -$1.2 million in 2025, then declined by 15.92% to -$1.4 million in 2026.
- The last three Net Cash Flow figures came in at -$1.4 million (Q1 2026), -$1.2 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -159.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -282.15 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 202.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 20.30 Mn |
| 10 | Profusa | - | - | - | -1.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.43 Mn |
| Mar 31, 2026 | -1.43 Mn |
| Dec 31, 2025 | -1.23 Mn |
| Dec 31, 2025 | -1.23 Mn |
| Sep 30, 2025 | 2.83 Mn |
| Sep 30, 2025 | 2.83 Mn |
| Jun 30, 2025 | -16,699.00 |
| Jun 30, 2025 | -16,699.00 |
| Mar 31, 2025 | 2,246.00 |
| Mar 31, 2025 | 2,246.00 |
| Dec 31, 2024 | 508,936.00 |
| Dec 31, 2024 | 508,936.00 |
| Sep 30, 2024 | 2.51 Mn |
| Sep 30, 2024 | 2.51 Mn |
| Jun 30, 2024 | 1,182.00 |
| Jun 30, 2024 | 1,182.00 |
| Mar 31, 2024 | 795.00 |
| Mar 31, 2024 | 795.00 |
| Dec 31, 2023 | -12,823.00 |
| Dec 31, 2023 | -12,823.00 |
| Sep 30, 2023 | 11,531.00 |
| Sep 30, 2023 | 11,531.00 |
| Jun 30, 2023 | -49,799.00 |
| Jun 30, 2023 | -49,799.00 |
| Mar 31, 2023 | -137,876.00 |
| Mar 31, 2023 | -137,876.00 |
| Dec 31, 2022 | -179,385.00 |
| Dec 31, 2022 | -179,385.00 |
| Sep 30, 2022 | -107,855.00 |
| Sep 30, 2022 | -107,855.00 |
| Jun 30, 2022 | -63,634.00 |
| Jun 30, 2022 | -63,634.00 |
| Mar 31, 2022 | -230,352.00 |
| Mar 31, 2022 | -230,352.00 |